|
CEROW CERo Therapeutics Holdings Inc 1870404 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-5,885,914.00 |
| Balance Sheet |
|
Current Assets
|
$1,574,398.00 |
|
Assets
|
$2,205,110.00 |
|
Current Liabilities
|
$11,327,100.00 |
|
Liabilities
|
$11,463,865.00 |
|
Equity
|
$-9,258,755.00 |
|
Shares Out
|
5845.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$2,800,000.00 |
|
Investing Cash Flow
|
$-7,944,740.00 |
| Market Analysis |
Market Cap
|
$491,720.00 |
|
PB
|
0.02 |
|
EPS
|
-0.20 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:57 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:02:02 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CEROW documents filed with the SEC.
CEROW Filings
Clear
